Chronic HCV Infection: Clinical Advances and Eradication Perspectives
Hepatitis C virus (HCV) chronic infection can determine liver fibrosis, cirrhosis and hepatocellular carcinoma, as well as several extra-hepatic manifestations (i.e., mixed cryoglobulinemia, metabolic syndrome, kidney disease, etc.). HCV infection is asymptomatic until severe stages of disease, thus...
Saved in:
Other Authors: | , |
---|---|
Format: | Electronic Book Chapter |
Language: | English |
Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2022
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000naaaa2200000uu 4500 | ||
---|---|---|---|
001 | doab_20_500_12854_79675 | ||
005 | 20220321 | ||
003 | oapen | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 20220321s2022 xx |||||o ||| 0|eng d | ||
020 | |a books978-3-0365-3362-9 | ||
020 | |a 9783036533612 | ||
020 | |a 9783036533629 | ||
040 | |a oapen |c oapen | ||
024 | 7 | |a 10.3390/books978-3-0365-3362-9 |c doi | |
041 | 0 | |a eng | |
042 | |a dc | ||
072 | 7 | |a M |2 bicssc | |
072 | 7 | |a MBNS |2 bicssc | |
100 | 1 | |a Liberto, Maria Carla |4 edt | |
700 | 1 | |a Marascio, Nadia |4 edt | |
700 | 1 | |a Liberto, Maria Carla |4 oth | |
700 | 1 | |a Marascio, Nadia |4 oth | |
245 | 1 | 0 | |a Chronic HCV Infection: Clinical Advances and Eradication Perspectives |
260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2022 | ||
300 | |a 1 electronic resource (104 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
520 | |a Hepatitis C virus (HCV) chronic infection can determine liver fibrosis, cirrhosis and hepatocellular carcinoma, as well as several extra-hepatic manifestations (i.e., mixed cryoglobulinemia, metabolic syndrome, kidney disease, etc.). HCV infection is asymptomatic until severe stages of disease, thus screening policy in the general population and in specific risk categories is necessary to allow for timely intervention. Despite a high sustained virological response by direct-acting antiviral drugs, a limited percentage of treated subject failed therapy according to resistance associated substitution carried on viral isolates and comorbidities in infected patients. Therefore, tailored therapy is required to cure HCV infection. Failure to comply with these conditions may impair success of HCV eradication expected by 2030. This Special Issue aims to discuss eradication perspectives related to therapy efficacy in patients with chronic diseases, developments in diagnostic procedures and improvements in screening policy. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
546 | |a English | ||
650 | 7 | |a Medicine |2 bicssc | |
650 | 7 | |a Epidemiology & medical statistics |2 bicssc | |
653 | |a HCV | ||
653 | |a rheumatic | ||
653 | |a interferon | ||
653 | |a mortality | ||
653 | |a hepatitis C virus (HCV) | ||
653 | |a phylogeny | ||
653 | |a resistance-associated substitution (RAS) | ||
653 | |a chronic hepatitis C | ||
653 | |a vibration controlled transient elastography | ||
653 | |a fibrosis | ||
653 | |a steatosis | ||
653 | |a hepatocellular carcinoma | ||
653 | |a hepatitis C | ||
653 | |a genotype 3 | ||
653 | |a liver cirrhosis | ||
653 | |a pangenotypic | ||
653 | |a children | ||
653 | |a ledipasvir/sofosbuvir | ||
653 | |a real-life | ||
653 | |a sustained virological response | ||
653 | |a elimination | ||
653 | |a model | ||
653 | |a COVID-19 | ||
653 | |a PWID | ||
653 | |a homeless persons | ||
653 | |a HCV eradication | ||
653 | |a direct-acting antivirals | ||
653 | |a out-of-hospital | ||
653 | |a retention in care | ||
653 | |a n/a | ||
856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/5060 |7 0 |z DOAB: download the publication |
856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/79675 |7 0 |z DOAB: description of the publication |